Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000843852 | SCV000985896 | likely benign | not provided | 2020-12-16 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000843852 | SCV001473681 | likely benign | not provided | 2019-11-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001514912 | SCV001722874 | benign | Osteogenesis imperfecta type I | 2025-01-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002372383 | SCV002625589 | likely benign | Cardiovascular phenotype | 2019-05-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics | RCV004997397 | SCV005621699 | benign | not specified | 2024-11-14 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004549914 | SCV004759891 | likely benign | COL1A1-related disorder | 2024-01-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |